Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 9 of 9 for “"CALR"”.

  1. New molecular and cellular aspects of mutant calreticulin in Myeloproliferative Neoplasms

    Calreticulin (CALR) is an endoplasmic reticulum (ER) protein that plays an important role as a calcium (Ca2+) buffering chaperone. Mutations in CALR exon 9 have been identified in essential thrombocythemia and primary myelofibrosis, two myeloproliferative neoplasms (MPNs) characterised by …

    salford Repository record for New molecular and cellular aspects of mutant calreticulin in Myeloproliferative Neoplasms (opens in a new tab)

  2. Caracterização clínica e molecular de pacientes com neoplasia mieloproliferativa crônica- cromossomo Ph- negativo

    … para receptor da trombopoetina (MPL) e no gene calreticulina (CALR). Ainda que a caracterização molecular desses pacientes seja uma ferramenta diagnóstica imprescindível, permanece sob estudo as implicações que essas alterações causam no fenótipo da doença. Neste trabalho realizamos a …

    brazil-ufpe Repository record for Caracterização clínica e molecular de pacientes com neoplasia mieloproliferativa crônica- cromossomo Ph- negativo (opens in a new tab)

  3. Detection of the calreticulin type 1 and type 2 mutations in a group of myeloproliferative neoplasm patients using molecular methods

    … (MF). In 2013, somatic mutations at exon 9 of CALR, the gene that encodes for calreticulin, were discovered through whole-exome sequencing and targeted re-sequencing in patients with MPNs. Among these mutations, more than 80% of CALR mutated patients possessed one of only two mutation types: …

    pretoria Repository record for Detection of the calreticulin type 1 and type 2 mutations in a group of myeloproliferative neoplasm patients using molecular methods (opens in a new tab)

  4. Investigating the anti-leukaemic effect of tamoxifen in the myeloproliferative neoplasms

    … or the multi-functional protein CALR (such as CALR<sup>Ins5</sup> and CALR<sup>Del52</sup>), causing the constitutive activation of signal transducer and activator of transcription (STAT) proteins. The selective oestrogen receptor modulator (SERM) tamoxifen (broadly used in ER+ …

    cambridge Repository record for Investigating the anti-leukaemic effect of tamoxifen in the myeloproliferative neoplasms (opens in a new tab)

  5. Molecular Mechanisms of Itch Sensations

    … and Itpr3), three histamine-dependent: S100a8, CALR and DSP) and one both-dependent: TRPV4) itch genes. Atp2a1 and Itpr3 were selected for further characterization. Atp2a1 and Itpr3 are involved in GRPR downstream Ca2+ signaling pathway for histamine-independent itch. GRPR is also expressed in …

    wustl Repository record for Molecular Mechanisms of Itch Sensations (opens in a new tab)

  6. Determinants of clinical phenotype in myeloproliferative neoplasms

    … in at least 5 patients, with mutations in JAK2, CALR, or MPL being the sole abnormality in 45% of the patients. The numbers of driver mutations increased with age and advanced disease. Driver mutations, germline polymorphisms, and demographic variables independently predicted whether patients …

    cambridge Repository record for Determinants of clinical phenotype in myeloproliferative neoplasms (opens in a new tab)

  7. Cytokine receptor-like factor 3 (CRLF3): A novel regulator of platelet biogenesis and potential drug target for thrombocythaemia

    … mutations in mainly Janus Kinas 2 $(JAK2)$, CALR and MPL cause essential thrombocythaemia $(ET)$. ET is a rare disease that leads to an increased risk of cardiovascular thrombotic events. Current treatment of ET uses combination of low dose aspirin to decrease platelet function and …

    cambridge Repository record for Cytokine receptor-like factor 3 (CRLF3): A novel regulator of platelet biogenesis and potential drug target for thrombocythaemia (opens in a new tab)